IL122249A0 - Fluorocarbon pharmaceutical formulations and their preparation - Google Patents

Fluorocarbon pharmaceutical formulations and their preparation

Info

Publication number
IL122249A0
IL122249A0 IL12224996A IL12224996A IL122249A0 IL 122249 A0 IL122249 A0 IL 122249A0 IL 12224996 A IL12224996 A IL 12224996A IL 12224996 A IL12224996 A IL 12224996A IL 122249 A0 IL122249 A0 IL 122249A0
Authority
IL
Israel
Prior art keywords
fluorocarbon
preparation
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
IL12224996A
Original Assignee
Alliance Pharmceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharmceutical Corp filed Critical Alliance Pharmceutical Corp
Publication of IL122249A0 publication Critical patent/IL122249A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12224996A 1995-06-07 1996-06-05 Fluorocarbon pharmaceutical formulations and their preparation IL122249A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48761295A 1995-06-07 1995-06-07
PCT/US1996/009064 WO1996040057A2 (en) 1995-06-07 1996-06-05 Reverse fluorocarbon emulsion compositions for drug delivery

Publications (1)

Publication Number Publication Date
IL122249A0 true IL122249A0 (en) 1998-04-05

Family

ID=23936452

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12224996A IL122249A0 (en) 1995-06-07 1996-06-05 Fluorocarbon pharmaceutical formulations and their preparation

Country Status (11)

Country Link
EP (1) EP0833608A2 (en)
JP (1) JPH11508237A (en)
KR (1) KR19990022354A (en)
CN (1) CN1195981A (en)
AU (1) AU704918B2 (en)
CA (1) CA2222063A1 (en)
HU (1) HUP9900879A2 (en)
IL (1) IL122249A0 (en)
NO (1) NO975321L (en)
PL (1) PL323931A1 (en)
WO (1) WO1996040057A2 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021541A2 (en) * 1997-10-24 1999-05-06 Alliance Pharmaceutical Corp. Amelioration of ischemic damage using synthetic oxygen carriers
AU1314899A (en) * 1997-11-10 1999-05-31 Sonus Pharmaceuticals, Inc. Emulsions for aerosolization and drug delivery
US6127430A (en) * 1998-12-16 2000-10-03 3M Innovative Properties Company Microemulsions containing water and hydrofluroethers
US6159917A (en) * 1998-12-16 2000-12-12 3M Innovative Properties Company Dry cleaning compositions containing hydrofluoroether
US6451286B1 (en) * 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US6312665B1 (en) * 1998-12-21 2001-11-06 Generex Pharmaceuticals Incorporated Aerosol formulations for buccal and pulmonary application
US6294153B1 (en) * 1998-12-21 2001-09-25 Generex Pharmaceuticals, Inc. Aerosol pharmaceutical formulation for pulmonary and nasal delivery
US6849263B2 (en) 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US6375975B1 (en) * 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
EP1338272A1 (en) * 1998-12-21 2003-08-27 Generex Pharmaceuticals Inc. Aerosol formulations for buccal and pulmonary application comprising chenodeoxycholate or deoxycholate
US6271200B1 (en) 1998-12-21 2001-08-07 Generex Pharmaceuticals Inc. Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
US7087215B2 (en) 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
US7357937B2 (en) 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
GB0307403D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
AU2003903296A0 (en) * 2003-06-30 2003-07-10 Raustech Pty Ltd Chemical compositions of matter
JPWO2006057429A1 (en) * 2004-11-24 2008-06-05 ナノキャリア株式会社 Methods for changing the morphology of block copolymers
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2481815B1 (en) 2006-05-11 2016-01-27 Raindance Technologies, Inc. Microfluidic devices
FR2903602B1 (en) * 2006-07-12 2012-10-26 Seppic Sa INJECTABLE FORMULATION WITH PROLONGED RELEASE OF ACTIVE INGREDIENTS, PROCESS FOR PREPARING THE SAME
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20110159078A1 (en) * 2008-01-22 2011-06-30 Vapogenix, Inc Volatile Anesthetic Compositions and Methods of Use
EP2123256A1 (en) 2008-05-19 2009-11-25 Ruhr-Universität Bochum Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
EP4047367A1 (en) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Method for detecting target analytes with droplet libraries
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
WO2011100604A2 (en) 2010-02-12 2011-08-18 Raindance Technologies, Inc. Digital analyte analysis
US9351943B2 (en) * 2010-07-01 2016-05-31 Matthew T. McLeay Anti-fibroblastic fluorochemical emulsion therapies
EP2587917A4 (en) * 2010-07-01 2015-05-06 Mtm Res Llc Anti-fibroblastic fluorochemical emulsion therapies
CN103228283A (en) * 2010-11-29 2013-07-31 千寿制药株式会社 Oil-in-water emulsion composition containing difluprednate and tobramycin
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
AU2012234259A1 (en) * 2011-03-31 2013-10-03 Libera-Korner, Jeanette Perfluorinated compounds for the non-viral transfer of nucleic acids
EP3709018A1 (en) 2011-06-02 2020-09-16 Bio-Rad Laboratories, Inc. Microfluidic apparatus for identifying components of a chemical reaction
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
AU2015274259B2 (en) * 2014-06-12 2019-04-18 Evan C. Unger Phospholipid composition and microbubbles and emulsions formed using same
US9699301B1 (en) * 2015-05-31 2017-07-04 Emma Michaela Siritzky Methods, devices and systems supporting driving and studying without distraction
CN109908085B (en) * 2019-04-23 2021-12-03 董红燕 Respiratory tract administration medicine carrier, its preparation method and application in preparing medicine for treating heart disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2720943B1 (en) * 1994-06-09 1996-08-23 Applic Transferts Technolo Stable inverse emulsions with a high concentration of fluorinated compound (s) and their use for the pulmonary administration of medicaments and for the manufacture of multiple emulsions.

Also Published As

Publication number Publication date
NO975321D0 (en) 1997-11-19
KR19990022354A (en) 1999-03-25
PL323931A1 (en) 1998-04-27
HU9900879D0 (en) 1999-05-28
AU704918B2 (en) 1999-05-06
CN1195981A (en) 1998-10-14
MX9709561A (en) 1998-10-31
WO1996040057A3 (en) 1997-02-20
CA2222063A1 (en) 1996-12-19
EP0833608A2 (en) 1998-04-08
WO1996040057A2 (en) 1996-12-19
JPH11508237A (en) 1999-07-21
HUP9900879A2 (en) 1999-08-30
AU6153796A (en) 1996-12-30
NO975321L (en) 1998-01-27

Similar Documents

Publication Publication Date Title
IL122249A0 (en) Fluorocarbon pharmaceutical formulations and their preparation
EG23826A (en) Pharmaceutical formulations
AP9600883A0 (en) Pharmaceutical formulations
IL124214A (en) Stable freeze-dried pharmaceutical formulation
GB9519363D0 (en) Pharmaceutical formulation
GB9408117D0 (en) Pharmaceutical formulations
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
GB9404248D0 (en) Pharmaceutical formulations
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
EP0862431A4 (en) Pharmaceutical formulation
IL114925A (en) Glycinamide derivatives their preparation and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL118672A (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
GB9523566D0 (en) Pharmaceutical formulation
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
EP0747351A3 (en) Thiocationic lipids, pharmaceutical compositions and methods of use thereof
ZA96392B (en) Pharmaceutical formulations
IL122872A0 (en) Quinoxaline-and quinoxalinylalkane-phosphonic acids their preparation and pharmaceutical compositions containing them
ZA967542B (en) Pharmaceutical combination preparation comprising keto-profen
GB9413542D0 (en) Pharmaceutical formulations
GB9500978D0 (en) Pharmaceutical formulations
HUP9900016A3 (en) Stable freeze-dried pharmaceutical formulation
ZA956970B (en) Improved pharmaceutical formulations their preparation and use
GB9516584D0 (en) Pharmaceutical formulations